about
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issuesAndres Lozano: Parkinson's, depression and the switch that might turn them offBAG5 inhibits parkin and enhances dopaminergic neuron degenerationUnbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseProceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.Deep brain stimulation for disorders of memory and cognitionA multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depressionChanges in cortical and pallidal oscillatory activity during the execution of a sensory trick in patients with cervical dystoniaGene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialThe subcallosal cingulate gyrus in the context of major depressionShort and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosisA Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.Intracranial applications of magnetic resonance-guided focused ultrasound.Improvement of pisa syndrome with contralateral pedunculopontine stimulation.Where are we with surgical therapies for Parkinson's disease?Neurocircuitry of limbic dysfunction in anorexia nervosa.Pallidal stimulation for dystonia.Deep brain stimulation for movement disorders: 2015 and beyond.Deep brain stimulation: postoperative issues.Novel surgical therapies for Tourette syndrome.Physiology of freezing of gait.Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5).Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders.Long-term hardware-related complications of deep brain stimulation.Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years.The most cited works in Parkinson's disease.Neuromodulation in epilepsy.Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.The surgical management of Parkinson's disease.Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease.Stimulation of the subthalamic nucleus and impulsivity: release your horsesProbing and regulating dysfunctional circuits using deep brain stimulation.Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders.Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases.A narrative history of the International Society for Psychiatric Surgery: 1970-1983.Neurogenic hippocampal targets of deep brain stimulation.Surgery of the motor thalamus: problems with the present nomenclatures.Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats.The globus pallidus, deep brain stimulation, and Parkinson's disease.Physiologic studies in the human brain in movement disorders.
P50
Q22253049-E8A548F2-0107-4FC4-9302-0C940925F97CQ23470173-BC7A029D-F22B-4854-8794-B427D991DEF9Q24322908-70D898A8-EB02-469C-9AD6-4D4C5D8469BFQ24336432-17589C08-6FEA-4D0F-9EDE-2A371A574569Q26752608-A0659665-DE82-40CF-B7AC-C209F89B9C5BQ26859169-AC567EB1-BE06-4F2F-B44C-4452CE071A10Q28253411-2F20C8FD-C147-4FC0-8DF2-98126124313CQ28288749-3532814E-AE80-421B-B773-D89FB0E99288Q28296434-9FD4B8F4-2FA4-420A-AD54-025C32720EEEQ28300223-2B55EB27-8B4C-40E7-9FAA-6D6E0223D1AFQ28534842-9957620C-9314-43E7-A518-ABB011337B3DQ30276072-165165BF-CFE1-4F7B-BE74-CCC888B0705FQ30384529-75F67BE5-78A0-4FC5-8817-742CED5B2594Q30538686-C28E09BF-1E4F-4E10-842A-C9C55B22D383Q30699327-1B7B15CB-2F58-42E4-8945-CC4A9C009A09Q30794135-71A1067D-6B5D-4ACC-BB45-7B8B8EF35C97Q30881128-601CA34F-5E78-41FB-9C9F-9595ABF220E6Q30976695-EF870FCD-558D-4DF1-9F8D-1D962B17F4E9Q31047638-BE61CE45-8A7D-48DA-B63E-9BCDD5561BDFQ31060931-B9417434-E58F-40B8-9E0A-1336EE5CA6D2Q31131953-2E736CF2-C9D8-40E8-BEB8-0BC4BA8D358FQ33831775-FDFB870C-3B53-4989-AFBB-246FEF77EE14Q34092378-11B12C9E-01B4-455D-B16B-C2173D824435Q34128924-4754FC33-E658-405E-8584-C1846AD94E36Q34162006-3C47F5FB-54D2-4919-BF8D-F099F7871FCCQ34175558-805F96FD-AC66-47D2-9AB1-1D0E2B508CF2Q34196412-0413228B-2863-4BD9-84DD-20D09ECB8FBDQ34206696-0D406DE7-2A2A-46A2-80F0-8A19800BEECDQ34207692-6A513D28-3117-40CF-9372-DC05444E9B02Q34273405-EC93D64E-F36E-4629-972B-3A1636305E20Q34273580-0BD3597A-EB40-4A75-8D92-E330368899EFQ34326989-19E6E57B-7A36-4361-ACBC-4017EF16C685Q34348568-994EDF52-8D7C-4462-B801-F381D785D4BEQ34384076-BCFB8B47-E228-4604-86C6-38F7341C6BB9Q34393556-74B7C9FD-CC41-4187-B8B9-B0B9CED2E1CFQ34589629-D93CC323-DFE6-45E9-9E03-879051046D57Q34596306-4599D5FE-535E-4910-8050-E00C3E020D8EQ34616128-384E90F9-4A83-44F2-A3A0-FE05D8634768Q34682175-A9850C6E-9FEB-44AD-B1FD-79E932F5B1B3Q34826234-D58DDE3E-5B1F-4001-B030-2882AD03587C
P50
description
Canadees wetenschapper
@nl
chair of neurosurgery at the University of Toronto
@en
científico canadiense
@es
kanadischer Wissenschaftler
@de
عَالِم كندي
@ar
name
Andres Lozano
@af
Andres Lozano
@an
Andres Lozano
@ast
Andres Lozano
@bar
Andres Lozano
@br
Andres Lozano
@ca
Andres Lozano
@co
Andres Lozano
@cs
Andres Lozano
@cy
Andres Lozano
@da
type
label
Andres Lozano
@af
Andres Lozano
@an
Andres Lozano
@ast
Andres Lozano
@bar
Andres Lozano
@br
Andres Lozano
@ca
Andres Lozano
@co
Andres Lozano
@cs
Andres Lozano
@cy
Andres Lozano
@da
prefLabel
Andres Lozano
@af
Andres Lozano
@an
Andres Lozano
@ast
Andres Lozano
@bar
Andres Lozano
@br
Andres Lozano
@ca
Andres Lozano
@co
Andres Lozano
@cs
Andres Lozano
@cy
Andres Lozano
@da
P106
P21
P2611
andres_lozano
P27
P31
P496
0000-0001-8257-3694
P569
2000-01-01T00:00:00Z